Pharmacologic Options for Aggressive Low-Density Lipoprotein Cholesterol Lowering: Benefits Versus Risks
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference28 articles.
1. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease;JAMA,1984
2. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia;Shepherd;N Engl J Med,1995
3. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels;Downs;JAMA,1998
4. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care;JAMA,2002
5. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA);Sever;Lancet,2003
Cited by 64 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Emerging Fixed-Dose Combination Treatments for Hyperlipidemia;Journal of Cardiovascular Pharmacology and Therapeutics;2019-03-25
2. Xantomas;EMC - Dermatología;2015-12
3. Ezetimibe for primary hypercholesterolemia;Cochrane Database of Systematic Reviews;2015-06-30
4. Use of ezetimibe results in more patients reaching lipid targets without side effects;Cor et Vasa;2014-04-01
5. Chinese Herbal Medicine on Dyslipidemia: Progress and Perspective;Evidence-Based Complementary and Alternative Medicine;2014
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3